PharMEDium Recalls Bupivacaine HCl Injectable Bags Due to Glass Particulate
PharMEDium Services, LLC is recalling 866 bags of 0.5% Bupivacaine HCl injectable solution because the active ingredient was contaminated with glass particulate.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall involving a sterile injectable drug contaminated with glass particulate, which poses a risk of significant injury or adverse health consequences, meeting the criteria for a Severe rating.
Plain-English summary
PharMEDium Services, LLC is voluntarily recalling 866 bags of 0.5% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride. The affected products are available in 250 mL and 500 mL Baxter Intravia bags and were compounded in Memphis, Tennessee. The recall was initiated because the active pharmaceutical ingredient (API) used to produce these sterile injectable drugs was contaminated with glass particulate.
The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences. The affected lots were distributed nationwide. Specific lot numbers and expiration dates are listed in the recall documentation, covering products with expiration dates ranging from May 2016 to July 2016.
Healthcare providers and patients should discontinue use of the affected lots immediately. Patients who have received these products should contact their healthcare provider for guidance. The recall is limited to the specific service codes and lot numbers identified in the official FDA notice.
The recalled product
- Product
- 0.5% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxter Intravia Bag, Service Code 2N1488 (NDC 61553-488-11), 500 mL in 500 mL Baxter Intravia Bag, Service Code 2N1489 (NDC 61553-489-01)Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Affected units
- 866
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Service Code 2N1488
- Lot Number 160520176M
- Exp. Date 5/22/2016
- Lot Number 160600059M
- Exp. Date 5/30/2016
- Lot Number 160970115M
- Exp. Date 7/5/2016
- Service Code 2N1489
- Lot Number 160490027C
- Exp. Date 5/19/2016
- Lot Number 160560032C
- Exp. Date 5/26/2016
- Lot Number 160620024C
- Exp. Date 6/1/2016
- Lot Number 160630029C
- Exp. Date 6/2/2016
- Lot Number 160670059C
- Exp. Date 6/6/2016
- Lot Number 160700047C
- Exp. Date 6/9/2016
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 75 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 75 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21